Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2018

Nov 14, 2018

SELL
$17.57 - $23.95 $653,604 - $890,940
-37,200 Closed
0 $0
Q2 2018

Aug 10, 2018

BUY
$11.6 - $19.27 $431,520 - $716,844
37,200 New
37,200 $712,000

Others Institutions Holding CARA

About Cara Therapeutics, Inc.


  • Ticker CARA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,725,900
  • Market Cap $14M
  • Description
  • Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...
More about CARA
Track This Portfolio

Track Quantitative Investment Management, LLC Portfolio

Follow Quantitative Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantitative Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quantitative Investment Management, LLC with notifications on news.